Molecular Imaging: Page 119

PET dose-painting methods produce discordant results

By Kathlyn Stone

As intensity-modulated radiation therapy becomes more sophisticated, oncologists are investigating new dose-painting methods to determine which areas of tumor target volume should receive additional radiation dose. But a new study indicates that two promising methods to guide dose painting actually produce sharply varied results.

August 26, 2008

Agfa integrates Barco 3D software

By AuntMinnieEurope.com staff writers

Image display and advanced visualization firm Barco said that a new version of its Voxar 3D advanced visualization software has been integated into Agfa HealthCare's Impax PACS software.

August 18, 2008

IBA, NeuroSurvival Technologies partner

By AuntMinnieEurope.com staff writers

Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed a collaboration agreement with molecular imaging and therapy developer NeuroSurvival Technologies (NST).

August 13, 2008

PET with C-11 PiB can assess beta-amyloid brain deposits

By Erik L. Ridley

PET using carbon-11-labeled Pittsburgh Compound B (C-11 PiB) shows promise for assessing beta-amyloid deposits in the brain and may have a potential role as a diagnostic aid for early Alzheimer's disease, according to research published online in the Archives of Neurology.

August 11, 2008

PET imaging reveals coronary vascular dysfunction in asymptomatic diabetics

By Reuters Health

NEW YORK (Reuters Health), Jun 24 - In a study of type 2 diabetics with no history or symptoms of heart disease, nearly all had evidence of coronary vascular dysfunction on PET imaging. Study results were presented in New Orleans at the 2008 SNM annual meeting.

June 23, 2008

French researchers develop handheld probe for SLN detection

By Wayne Forrest

NEW ORLEANS - Researchers from France have developed a handheld gamma camera to perform lymphoscintigraphy for sentinel lymph node (SLN) localization in breast cancer. They presented details of the device and results of a prospective clinical study comparing it with a conventional gamma camera during the 2008 SNM annual meeting.

June 16, 2008

IBA, Wilex ink licensing pact

By AuntMinnieEurope.com staff writers

Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed a licensing agreement for the worldwide marketing, distribution, and sales of Redectane from Wilex of Munich, Germany.

June 5, 2008

PETNet gets U.K. FDG license

By AuntMinnieEurope.com staff writers

Siemens Healthcare said that its PETNet Solutions division has received a full Marketing Authorization and Manufacturer's/Importer's (MIA) license to produce and distribute its FDG biomarker from its Nottingham City Hospital site.

May 11, 2008

Open-source software delivers 3-way (PET/CT/MR) image fusion

By Rob Skelding

There is a growing tendency for MR images to be viewed in combination with PET and/or CT in the quest for more accurate diagnoses of complex diseases. While hybrid PET/MR machines have yet to reach the market, a new open-source software application offers radiologists a way to create three-way PET/CT/MR image fusion.

April 24, 2008

Siemens launches PETNet in India

By AuntMinnieEurope.com staff writers

Siemens Healthcare of Erlangen, Germany, has opened its first PETNet Solutions radiopharmaceutical production facility in India.

March 25, 2008

IBA opens U.K. production center

By AuntMinnieEurope.com staff writers

Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has received the go-ahead from U.K. authorities to begin operations at its new PET radiopharmaceuticals production site in Guildford, U.K., according to the company.

March 13, 2008

European molecular imaging market grows

By AuntMinnieEurope.com staff writers

The European molecular imaging market continues to expand, despite low reimbursement rates, pricing pressures, and high competition levels, according to market research firm Frost & Sullivan.

March 11, 2008

Previous Page

Page 119 of 122

Next Page